PureTech Health Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 11
- Investments
- 54
- Portfolio
- 7
- Exits
- 18
PureTech Health General Information
Description
Founded in 2001, PureTech Ventures is a venture capital firm based in Boston, Massachusetts. The firm prefers to invest in seed and early-stage companies operating in the life sciences, therapeutics, medical devices, pharmaceuticals, metabolism, neuroscience, drug delivery, immunology, and platform technologies sectors.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
- 6 Tide Street
- Boston, MA 02210
- United States
+1 (617) 000-0000
PureTech Health Investments & Acquisitions (54)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Akili Interactive | 26-Jan-2022 | PIPE | 00000 | Other Healthcare Technology Systems | Generating Revenue | 00000 00000000 00.0 |
| 0000000 | 14-Jan-2022 | 0000 | 00000 | Drug Discovery | Generating Revenue | 0000000 00000 00 |
| 0000000 0000000000 | 21-Jul-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 0000000 00000000 00.0 |
| 0000000 0000000000 | 16-Apr-2021 | 000000000 00 | Drug Discovery | Clinical Trials - Phase 2 | 0000000 00000000 00.0 | |
| 0000000 | 18-Jan-2021 | 000000000 00 | Drug Discovery | Generating Revenue | 0000000 00000 00 | |
| 000 000000000 | 07-Jul-2020 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue/Not Profitable | 0000000 00000000 00.0 |
| 00000000 000 | 02-Oct-2019 | 000000000000 | Other Healthcare Services | Generating Revenue | ||
| 0000000 0000000000 | 23-Sep-2019 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | 0000000 00000000 00.0 |
| Vedanta Biosciences | 13-May-2019 | Later Stage VC | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | 0000000 00000000 00.0 |
| Sonde | 11-Apr-2019 | Later Stage VC | 0000 | Decision/Risk Analysis | Generating Revenue | 0000 000000 00.0 |
PureTech Health Exits (18)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Gelesis | 14-Jan-2022 | Reverse Merger | 00000 |
| 000 000000000 | 05-Feb-2021 | 000 | 00000 |
| 000000 00000000000 | 26-Aug-2020 | 000000000 00000000 | 00000 |
| 000000 00000000000 | 28-Jun-2019 | 000 | 00000 |
| 00000000 | 01-Dec-2018 | 000 00 00000000 | |
| 00000 000000000 | 18-Jul-2018 | 000000000000000000 | |
| 000 0000000 | 01-Jul-2018 | 000 00 00000000 | |
| 0000000 0000000000 | 01-Apr-2018 | 000 00 00000000 | |
| Knode | 01-Apr-2018 | Out of Business | |
| Sync Project | 20-Feb-2018 | Merger/Acquisition |
PureTech Health Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialPureTech Health Team (45)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Daphna Zohar | Chief Executive Officer & Director | 00 | 0 | 0 | Boston, MA |
| George Farmer Ph.D | Chief Financial Officer, Finance | Boston, MA | |||
| Frank Douglas Ph.D | Senior Partner Emeritus | 0 | 0 | Boston, MA | |
| Joseph Bolen Ph.D | Chief Scientific Officer | 0 | 0 | 0 | Boston, MA |
| William Berry | Controller | Boston, MA |
PureTech Health Co-Investors (44)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 2 | 0 |
|
|
|
| Invesco | 0 | 0 |
|
|
|
| 5AM Ventures | 0 | 0 |
|
|
|
| Magnetar Capital | 0 | 0 |
|
|
|
| Wellcome Trust | 0 | 0 |
|
|